Front Row Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-365
Closed -$2 982
2018
Q2
$2 Buy
365
+16
+5% ﹤0.01% 820
2018
Q1
$3K Buy
349
+275
+372% +$2.36K ﹤0.01% 684
2017
Q4
$1K Buy
+74
New +$1K ﹤0.01% 744